BLGO - BioLargo, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue281.106127.582111.547
Cost of Revenue105.87762.06755.999
Gross Profit175.22965.51555.548
Operating Expenses
Research Development1,381.956684.554642.923
Selling General and Administrative3,714.3983,551.5222,793.119
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-4,934.861-4,181.481-3,391.414
Income from Continuing Operations
Total Other Income/Expenses Net-10.3799.12299.122
Earnings Before Interest and Taxes-4,945.231-4,082.359-3,391.414
Interest Expense3,129.104994.671348.153
Income Before Tax-8,074.335-5,077.03-3,739.567
Income Tax Expense---
Minority Interest554.969789.57360.627
Net Income From Continuing Ops-7,839.731-5,055.976-3,692.116
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,839.731-5,055.976-3,692.116
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,839.731-5,055.976-3,692.116